Skip to main content
Clinical Trials/NCT06713707
NCT06713707
Completed
Not Applicable

Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Patients with Parkinson's Disease

Gazi University1 site in 1 country40 target enrollmentNovember 28, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Gazi University
Enrollment
40
Locations
1
Primary Endpoint
Minnesota Manual Dexterity Test
Status
Completed
Last Updated
last year

Overview

Brief Summary

Parkinson's Disease (PD) is a disease that affects upper extremity functional skills with clinical findings such as bradykinesia, rigidity, and hypokinesia, and causes limitations in patients' daily life activities. The impairment of upper extremity functional skills is related to the deficiency in planning both voluntary and complex movements, as well as the deficiency in multiple motor planning. In particular; fine manual dexterity, reaching, and grasping movements are affected, greatly affecting patients' daily activities. Therefore, upper extremity evaluations are an important issue to consider for training upper extremity motor skills in PD. There are minimal assessment tools for evaluating the upper extremity functions of individuals with PD. The Nine-Hole Peg Test and the Jebsen Hand Function Evaluation Test are the most commonly used scales in the evaluation of the upper extremity in PD, and their validity and reliability have been demonstrated. These scales roughly evaluate both extremities separately. However, these scales are not suitable assessment tools for testing activities in which both extremities are frequently used in daily life. Therefore, there is a need for valid and reliable scales that can evaluate upper extremity activities both in isolation and bilaterally. The Minnesota manual dexterity test (MMDT) allows both hands to be evaluated together. It also evaluates hand-eye coordination and gross motor skills in addition to manual dexterity. MMDT is used in individuals with PD, but there is no study in the literature examining the validity and reliability of the scale. Therefore, this study aims to evaluate the reliability and validity of MMDT in individuals with PD.

Detailed Description

At baseline, the MMDT, 9-hole peg test, and Jebsen-Taylor Hand Function Test (JTHFT) will be applied to the MS group. The MMDT will be repeated seven days after the first application in MS. Healthy controls are going to perform only the MMDT.

Registry
clinicaltrials.gov
Start Date
November 28, 2024
End Date
January 15, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sefa Eldemir

Research Assistant

Cumhuriyet University

Eligibility Criteria

Inclusion Criteria

  • Between 40-80 years old
  • Diagnosed with only "Parkinson's Disease" by a neurologist
  • Between 1-3 values of your thoughts according to Hoehn and Yahr manufacturers

Exclusion Criteria

  • Having any vision, hearing or perception problems that may affect the research results,
  • Having an orthopedic problem that may affect manual skills in the upper extremity,
  • Having a cardiovascular, pulmonary disorder

Outcomes

Primary Outcomes

Minnesota Manual Dexterity Test

Time Frame: baseline (on the predetermined assessment day)

The Minnesota Manual Dexterity Test (MMDT) is a performance test designed to evaluate hand functions and hand-eye coordination both unilaterally and bilaterally, higher scores mean a worse outcome

Minnesota Manual Dexterity Test-second

Time Frame: the second assessment will be conducted after the one week

The Minnesota Manual Dexterity Test (MMDT) is a performance test designed to evaluate hand functions and hand-eye coordination both unilaterally and bilaterally, higher scores mean a worse outcome

Secondary Outcomes

  • 9-Hole Peg Test(baseline (on the predetermined assessment day))
  • The Jebsen Hand Function Test(baseline (on the predetermined assessment day))

Study Sites (1)

Loading locations...

Similar Trials